0001104659-23-099019.txt : 20230907
0001104659-23-099019.hdr.sgml : 20230907
20230907175334
ACCESSION NUMBER: 0001104659-23-099019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MISRA TUSHAR
CENTRAL INDEX KEY: 0001877233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38129
FILM NUMBER: 231243227
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mersana Therapeutics, Inc.
CENTRAL INDEX KEY: 0001442836
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-498-0020
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MERSANA THERAPEUTICS INC
DATE OF NAME CHANGE: 20080813
4
1
tm2325674-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-05
0
0001442836
Mersana Therapeutics, Inc.
MRSN
0001877233
MISRA TUSHAR
C/O MERSANA THERAPEUTICS, INC.
840 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Chief Manuf. Officer
0
Restricted stock unit
2023-09-05
4
A
0
50000
0
A
Common Stock
50000
50000
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the Issuer.
The RSUs will vest on October 1, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date.
/s/ Alejandra Carvajal, as attorney-in-fact
2023-09-07